Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer

Increased insulin-like growth factor (igf) signalling has been observed in breast cancer, including endocrine-responsive cancers, and has been linked to disease progression and recurrence. In particular, igf-1 has the ability to induce and promote lymphangiogenesis through the induction of vascular...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Morgillo, F., De Vita, F., Antoniol, G., Orditura, M., Auriemma, P.P., Diadema, M.R., Lieto, E., Savastano, B., Festino, L., Laterza, M.M., Fabozzi, A., Ventriglia, J., Petrillo, A., Ciardiello, F., Barbarisi, A., Iovino, F.
Format: Artigo
Langue:Inglês
Publié: Multimed Inc. 2013
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3728056/
https://ncbi.nlm.nih.gov/pubmed/23904766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.20.1380
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires